// App-Quantinova.ai

: Enhanced immune activation pathways enriched in patients =70 years with severe COVID-19

Researchers

Presenter

  • Luke O'Neill

Principal Investigators

  • Charlotte Summers

  • Gift Nyamundanda

  • Johannes Freudenberg

  • Anubha Gupta

  • Julia Smith

  • Sumanta Mukherjee

  • Jessica Neisen

Medical Centers

  • GlaxoSmithKline, Hertfordshire, United Kingdom.

  • University of Cambridge, Cambridge, United Kingdom

  • GlaxoSmithKline plc, Collegeville, United States of America

  • Trinity Biomedical Sciences Institu, DUBLIN, Ireland

  • GlaxoSmithKline plc, Collegeville, United States of America

Locations

  • United States

  • United Kingdom

  • Ireland

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • Otilimab

Outcome

  • N/A

Study Design

  • Placebo Control

Phase

  • N/A

Study Id's

  • NCT04376684

Sponsors

  • Fishawack Indicia Ltd

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved